UNIGE document Scientific Article - Case report
previous document  unige:25714  next document
add to browser collection
Title

Hypereosinophilia in patients with multiple sclerosis treated with natalizumab
Authors
Abbas, Mohamed
Lalive d'Epinay, Patrice
Chofflon, Michel
Simon, H-U
Chizzolini, Carlo
Ribi, Camillo
Published in Neurology. 2011, vol. 77, no. 16, p. 1561-4
Abstract To report asymptomatic hypereosinophilia as a potential side effect in patients treated with natalizumab, an α-4 integrin blocking agent.
Keywords Adult — Antibodies, Monoclonal, Humanized/therapeutic use — Female — Humans — Hypereosinophilic Syndrome/complications/drug therapy — Middle Aged — Multiple Sclerosis/complications/drug therapy
Identifiers
PMID: 21975205
Full text
Article (Published version) (248 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques
Research groups Scléroses en plaques, neuroimmunologie, encéphalite autoimmune expérimentale (843)
La matrice extracellulaire (651)
Citation
(ISO format) 		ABBAS, Mohamed et al. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. In: Neurology, 2011, vol. 77, n° 16, p. 1561-4. https://archive-ouverte.unige.ch/unige:25714

345 hits

0 download

Contact an author

Update request

Update

Deposited on : 2013-01-18

Export document
Format :
Citation style :